Neoplasm observable

Code	`395531003`
Semantic tag	observable entity
Module	international
Definition	primitive
Effective time	20220930

371498006Additional pathologic finding in tumour specimen observable entity

445104009Allred score for neoplasm observable entity

397440000Anatomic location of excised lymph node containing metastatic neoplasm observable entity

371480007Anatomic location of neoplasm observable entity

444775005Average intensity of positive staining neoplastic cells observable entity

1365742006Average number of HER2 signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization observable entity

1365743001Average number of chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization observable entity

146611000146107Breast Imaging Reporting and Data System assessment category observable entity

443772002Clockface position of neoplasm observable entity

399574005Degree of pigmentation of tumour observable entity

1285455002Detection of neoplasm in blood observable entity

1285453009Detection of neoplasm in body fluid observable entity

396987006Distance from anterior edge of tumour to limbus of cornea at cut edge, after sectioning observable entity

399514000Distance of anterior margin of tumour base from limbus of cornea at cut edge, after sectioning observable entity

396988001Distance of posterior margin of tumour base from edge of optic disc, after sectioning observable entity

371490004Distance of tumour from anal verge observable entity

385357003Dukes stage observable entity

443941007Edition of American Joint Committee on Cancer TNM staging system manual observable entity

1367633006European Thyroid Imaging and Reporting Data System score observable entity

385361009FIGO stage for gynaecological malignancy observable entity

396893004Functional status of pancreatic endocrine tumour observable entity

258263003Generic tumour extent observable entity

396984004Histologic feature of neoplasm observable entity

405916000Intergroup rhabdomyosarcoma study post-surgical clinical group observable entity

409728006International neuroblastoma pathology classification observable entity

1285487004Intraoperative presence of metastasis in sentinel lymph node by one-step nucleic acid amplification observable entity

1363322003Laterality of lymph nodes with metastatic malignant neoplasm observable entity

1363321005Laterality of primary malignant neoplasm of larynx observable entity

1286852000Laterality of primary malignant neoplasm of oral soft tissue observable entity

1286919007Laterality of primary malignant neoplasm of pharynx observable entity

1363323008Laterality of primary malignant neoplasm of salivary gland observable entity

263605001Length dimension of neoplasm observable entity

1279923008Length of largest lymph node with metastatic neoplasm in excised specimen observable entity

385300008Linear extent of involvement of carcinoma observable entity

40151000234104Liver Imaging Reporting and Data System score observable entity

425133002Location of malignant melanoma in specimen with involved deep margin observable entity

424696000Location of malignant melanoma in specimen with uninvolved lateral margin observable entity

422796005Location of melanoma in situ in specimen with uninvolved lateral margin observable entity

406013004Location of tumour in relation to closest lateral margin observable entity

399725006Location of tumour within eye observable entity

406014005Location of tumour within lateral margin observable entity

1362105002Lung Imaging Reporting and Data System category observable entity

397447002Lymphoma extent of involvement observable entity

1290247007Mitotic-karyorrhectic index observable entity

103420007Modified Dukes stage observable entity

405931009National Wilms Tumour Study Group Stage observable entity

371503009Neoplasm weight observable entity

3010001000004101Nottingham mitotic count in primary malignant neoplasm of breast observable entity

444644009Number fraction of oestrogen receptors in neoplasm using immune stain observable entity

445366002Number fraction of progesterone receptors in neoplasm using immune stain observable entity

443527007Number of lymph nodes containing metastatic neoplasm in excised specimen observable entity

1256030002Number of metastatic discontinuous tumour deposits of primary malignant neoplasm of appendix observable entity

1286756005Number of metastatic discontinuous tumour deposits of primary malignant neoplasm of colorectum observable entity

246214002Number of neoplasms in excised tissue specimen observable entity

372282003Number of positive prostatic tissue chips obtained by resection observable entity

399589001Number of tissue chips positive for carcinoma observable entity

1286758006Number of tumour buds in primary malignant neoplasm of colorectum in microscopic field 0.785 square millimetre observable entity

405930005Number of tumour nodules observable entity

399483003Organ AND/OR tissue involved by tumour observable entity

1367645002Ovarian-Adnexal Reporting and Data System score observable entity

405978005Pathologic stage observable entity

1363492009Percent acinar histologic architectural pattern in adenocarcinoma of lung in excised lung specimen observable entity

1363297000Percent lepidic histologic architectural pattern in adenocarcinoma of lung in excised lung specimen observable entity

1363494005Percent micropapillary histologic architectural pattern in adenocarcinoma of lung in excised lung specimen observable entity

1255078008Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm by immunohistochemistry observable entity

1234804006Percent of cells with oestrogen receptor in primary malignant neoplasm of breast by immunohistochemistry observable entity

1234803000Percent of cells with progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry observable entity

1287132008Percent of neoplasm in primary malignant mixed germ cell tumour of testis observable entity

1363493004Percent papillary histologic architectural pattern in adenocarcinoma of lung in excised lung specimen observable entity

1363495006Percent solid histologic architectural pattern in adenocarcinoma of lung in excised lung specimen observable entity

1285137001Percent thickness of myometrial wall directly invaded by adenosarcoma in uterus specimen observable entity

1285327002Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy observable entity

444916005Percentage of carcinoma in situ in neoplasm observable entity

1290243006Percentage of immature teratoma involved by immature elements observable entity

405921002Percentage of neoplasm involved by necrosis observable entity

1525831000004108Percentage of primary malignant neoplasm of prostate in resected prostate specimen observable entity

1287180006Percentage of primary malignant neoplasm of prostate with Gleason histologic pattern 4 observable entity

399653000Percentage of sarcomatoid element in tumour observable entity

445234005Percentage span of neoplasm consisting of epithelium observable entity

445233004Percentage span of neoplasm consisting of stroma observable entity

1255768001Presence of ALK tyrosine kinase receptor in primary malignant neoplasm of lung by immunohistochemistry observable entity

1286752007Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of colorectum by immunohistochemistry observable entity

1255083000Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of endometrium by immunohistochemistry observable entity

1255098003Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of lung by immunohistochemistry observable entity

1286764004Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of colorectum by immunohistochemistry observable entity

1255089001Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of endometrium by immunohistochemistry observable entity

1255099006Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of lung by immunohistochemistry observable entity

1286763005Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of colorectum by immunohistochemistry observable entity

1255090005Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of endometrium by immunohistochemistry observable entity

1255100003Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of lung by immunohistochemistry observable entity

1363306004Presence of adenocarcinoma in air spaces of pulmonary alveoli in resected lung specimen observable entity

1279996006Presence of anaplasia in malignant neoplasm observable entity

1255615003Presence of anoctamin-1 in primary gastrointestinal stromal sarcoma by immunohistochemistry observable entity

1365755007Presence of carcinoma in situ in excised breast specimen observable entity

1366173006Presence of cribriform carcinoma in malignant neoplasm of prostate in excised specimen observable entity

371487005Presence of direct invasion by neoplasm observable entity

2900001000004101Presence of ductal carcinoma in situ in epidermis of nipple observable entity

1370852004Presence of germ cell neoplasia in situ in malignant neoplasm of testis observable entity

1366195005Presence of germ cell neoplasia in situ in resected prostate specimen observable entity

1275630008Presence of hepatoblastoma in serous capsule of liver in excised specimen observable entity

1268932000Presence of implants of primary malignant neoplasm of uterine adnexa observable entity

1366172001Presence of intraductal carcinoma and/or cribriform carcinoma in malignant neoplasm of prostate in excised specimen observable entity

1281845003Presence of invasive ductal carcinoma with extensive intraductal carcinoma in excised breast specimen observable entity

1300184003Presence of macroscopic perforation of colorectum by primary malignant neoplasm of colorectum observable entity

1255614004Presence of mast/stem cell growth factor receptor Kit in primary gastrointestinal stromal sarcoma by immunohistochemistry observable entity

1285486008Presence of metastasis in sentinel lymph node using touch imprint cytology during surgical procedure observable entity

1730561000004108Presence of metastatic discontinuous spread of primary malignant neoplasm observable entity

1268302004Presence of metastatic neoplasm in lymph node in excised tissue specimen observable entity

396786009Presence of metastatic neoplasm in non-regional lymph node observable entity

399656008Presence of metastatic neoplasm in regional lymph node observable entity

1264484006Presence of microsatellite of malignant melanoma observable entity

1286762000Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of colorectum by immunohistochemistry observable entity

1255091009Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of endometrium by immunohistochemistry observable entity

1255097008Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of lung by immunohistochemistry observable entity

1287179008Presence of necrosis in ductal carcinoma in situ in excised breast specimen observable entity

371488000Presence of neoplasm at excised surgical margin observable entity

1287135005Presence of neoplasm in mesentery observable entity

1264289004Presence of nephrogenic rests in primary nephroblastoma observable entity

1264483000Presence of neurotropism in malignant melanoma of skin observable entity

445028008Presence of oestrogen receptor in neoplasm observable entity

445029000Presence of progesterone receptor in neoplasm observable entity

1255770005Presence of programmed cell death 1 ligand 1 in primary malignant neoplasm of lung by immunohistochemistry observable entity

1255769009Presence of proto-oncogene tyrosine-protein kinase ROS in primary malignant neoplasm of lung by immunohistochemistry observable entity

3550001000004108Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of breast by immunohistochemistry observable entity

1363314005Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of breast by in situ hybridisation observable entity

1255095000Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of endometrium by immunohistochemistry observable entity

1255771009Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of lung by immunohistochemistry observable entity

1256123005Presence of regression of metastatic neoplasm of breast in lymph node after neoadjuvant antineoplastic therapy observable entity

1255605009Presence of regression of primary malignant melanoma of skin observable entity

1255588004Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy observable entity

1285517009Presence of regression of primary malignant neoplasm of prostate after hormone therapy observable entity

1285516000Presence of regression of primary malignant neoplasm of prostate after radiotherapy therapy observable entity

1255616002Presence of succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry observable entity

1255617006Presence of succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry observable entity

1286751000Presence of tumour bud in primary malignant neoplasm of colorectum observable entity

1285296002Presence of tumour necrosis in malignant neoplasm of bone in excised tissue specimen observable entity

1269402006Presence of tumour necrosis in malignant neoplasm of kidney in excised kidney specimen observable entity

1287172004Presence of tumour necrosis in malignant neoplasm of soft tissue in excised specimen observable entity

1279927009Presence of tumour necrosis in malignant neoplasm of thyroid in thyroidectomy specimen observable entity

6270001000004106Presence of ulcer in primary malignant melanoma of skin observable entity

371510003Proportion of specimen involved by tumour observable entity

444901007Proportion score of neoplastic cells positive for hormone receptors using immunohistochemistry observable entity

350501000146102Prostate Imaging-Reporting and Data System score observable entity

422973004Radial location of malignant melanoma in peripheral surgical margin of excised specimen of skin observable entity

424082007Radial location of melanoma in situ in peripheral surgical margin of excised skin specimen observable entity

1290348000Radial location of neoplasm in excised breast specimen observable entity

1365744007Ratio of erb-b2 receptor tyrosine kinase 2 to chromosome 17 centromere signals per cell in malignant neoplasm of breast in excised tissue specimen by in situ hybridization technique observable entity

399429001Region of fallopian tube involved by tumour observable entity

1286943005Relative location of involved inguinal lymph nodes to primary malignant neoplasm of penis observable entity

1287131001Relative location of involved lymph nodes to primary malignant neoplasm of nasal cavity and/or nasal sinus observable entity

1286862007Relative location of involved lymph nodes to primary malignant neoplasm of oral soft tissue observable entity

1286920001Relative location of involved lymph nodes to primary malignant neoplasm of pharynx observable entity

1286891005Relative location of involved lymph nodes with primary malignant neoplasm of major salivary gland observable entity

444782009Residual cancer burden index observable entity

17964000Residual tumour stage observable entity

399424006Serum tumour marker category observable entity

443787007Site involved by extension of neoplasm observable entity

399613003Site of invasive ovarian tumour omental implant observable entity

397443003Site of largest single mass observable entity

397512008Site of non-invasive (desmoplastic) ovarian tumour omental implant observable entity

397510000Site of non-invasive (epithelial) ovarian tumour omental implant observable entity

371495009Stage of tumour involvement of non-regional lymph nodes observable entity

396210009Status of adrenal gland involvement by tumour observable entity

425911000Status of correlation between radiographic image and pathologic finding observable entity

399608002Status of distant metastasis observable entity

384604004Status of intratumoral/peritumoral lymphocyte response observable entity

399428009Status of invasive ovarian tumour omental implants observable entity

397511001Status of non-invasive (desmoplastic) ovarian tumour omental implants observable entity

397505004Status of non-invasive (epithelial) ovarian tumour omental implants observable entity

399668004Status of ovarian tumour omental implants observable entity

396432002Status of regression of tumour observable entity

405926007Status of renal sinus involvement by tumour observable entity

445200009Status of residual neoplasm observable entity

313137003Status of serum tumour marker level observable entity

399489004Status of specimen involvement by macroscopic tumour observable entity

444696007Status of specimen involvement by multifocal invasion observable entity

396406008Status of specimen involvement by satellite nodule(s) observable entity

396395003Status of tumour infiltration by lymphocytes observable entity

405909001Status of tumour involvement by necrosis observable entity

396324006Surgical margin involved by neoplasm in excised tissue specimen observable entity

399631002TNM tumour observable observable entity

40161000234102Thyroid Imaging Reporting and Data System score observable entity

370110004Tumour border behaviour observable entity

1286754008Tumour bud score in primary malignant neoplasm of colorectum observable entity

371500007Tumour configuration observable entity

396402005Tumour extent of invasion, macroscopic observable entity

396199003Tumour focality observable entity

310871000000100Tumour hormone receptor status observable entity

371511004Tumour immunophenotyping status observable entity

396985003Tumour location after sectioning observable entity

406084004Tumour nodule site observable entity

396410006Tumour pigmentation observable entity

385404000Tumour quantitation observable entity

371508000Tumour stage observable entity

396793008Tumour viability observable entity

258261001Tumour volume observable entity

406126002Type of polyp from which malignant neoplasm originated observable entity

396926000Type of study performed on tumour specimen observable entity

397005006WHO tumour classification observable entity

397006007WHO tumour classification cannot be determined observable entity

Synonyms

Parents (1)

Children (200)